Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
European Journal of Haematology
|
April 1, 1990
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA
G Avvisati, F Mandelli, M C Petti, et al.
Haematologica
|
May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemia
M C Petti, M A Aloe Spiriti, A M Carella, et al.
Leukemia
|
April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia
A Spadea, M C Petti, P Fazi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)
S Keating, T de Witte, S Suciu, et al.
British Journal of Haematology
|
April 8, 1998
Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
L Pagano, L Annino, A Ferrari, et al.
Blood
|
May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis
I Cordone, S Masi, F R Mauro, et al.
British Journal of Haematology
|
September 12, 1998
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases
C Guglielmi, M P Martelli, D Diverio, et al.
Haematologica
|
September 8, 1999
Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo
I Majolino, M Vignetti, G Meloni, et al.
British Journal of Haematology
|
September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
S Keating, T de Witte, S Suciu, et al.
Bone Marrow Transplantation
|
June 1, 1996
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups
S Keating, S Suciu, T de Witte, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
European Journal of Haematology
|
April 1, 1990
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA
G Avvisati, F Mandelli, M C Petti, et al.
Haematologica
|
May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemia
M C Petti, M A Aloe Spiriti, A M Carella, et al.
Leukemia
|
April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia
A Spadea, M C Petti, P Fazi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)
S Keating, T de Witte, S Suciu, et al.
British Journal of Haematology
|
April 8, 1998
Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
L Pagano, L Annino, A Ferrari, et al.
Blood
|
May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis
I Cordone, S Masi, F R Mauro, et al.
British Journal of Haematology
|
September 12, 1998
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases
C Guglielmi, M P Martelli, D Diverio, et al.
Haematologica
|
September 8, 1999
Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo
I Majolino, M Vignetti, G Meloni, et al.
British Journal of Haematology
|
September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
S Keating, T de Witte, S Suciu, et al.
Bone Marrow Transplantation
|
June 1, 1996
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups
S Keating, S Suciu, T de Witte, et al.
Page
of 3